Chadwick Jeremy G

CIK 00013884062 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001388406

Recent Transactions

50 trades

Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-27$81.50/sh−3,679→ 44,618 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-27$82.08/sh−600→ 44,018 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-26$79.39/sh−3,800→ 53,348 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-26$80.71/sh−551→ 48,297 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-26$80.02/sh−4,500→ 48,848 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-26$79.17/sh−324→ 57,148 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-05-26$78.36/sh−3,730→ 57,472 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-04-22−100→ 45,434 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-22$43.50/sh+200→ 61,502 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-22$30.17/sh+100→ 61,302 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-04-22−200→ 58,263 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-22$90.00/sh−300→ 61,202 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-15$90.00/sh−1,300→ 61,202 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-15$43.50/sh+1,300→ 62,502 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-04-15−1,300→ 58,463 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-14$43.50/sh+785→ 66,453 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-04-14−785→ 59,763 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-04-14−4,466→ 45,534 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-14$90.00/sh−5,251→ 61,202 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-14$30.17/sh+4,466→ 65,668 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-01$86.05/sh−1,100→ 61,202 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-01$29.64/sh+14,640→ 75,842 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-04-01−14,640→ 68,633 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-04-01$85.41/sh−13,540→ 62,302 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-31$85.38/sh−7,600→ 61,202 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-03-31−7,600→ 83,273 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-31$29.64/sh+7,600→ 68,802 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-25$29.64/sh+24,727→ 85,929 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-25$80.26/sh−24,727→ 61,202 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-03-25−24,727→ 90,873 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-23$79.87/sh−6,105→ 62,402 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-23$29.64/sh+84,400→ 152,452 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-23$76.73/sh−22,756→ 129,696 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-23$77.21/sh−52,975→ 76,721 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-23$78.40/sh−8,214→ 68,507 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-23$80.05/sh−1,200→ 61,202 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-03-23−84,400→ 115,600 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-11$43.50/sh+20,000→ 93,810 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-03-11−20,000→ 60,548 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-11$83.72/sh−11,111→ 68,052 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-11$83.10/sh−12,882→ 79,163 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-11$82.13/sh−1,765→ 92,045 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-04$85.78/sh−1,150→ 74,168 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-04$84.00/sh−394→ 77,335 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-04$86.62/sh−358→ 73,810 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-04$85.04/sh−2,017→ 75,318 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-02$87.75/sh−549→ 79,219 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-03-02+25,150→ 25,150 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-02$89.66/sh−1,107→ 77,729 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-03-02$88.50/sh−383→ 78,836 total

Companies

Recent Filings

Address

C/O KYMERA THERAPEUTICS, INC. 500 NORTH BEACON STREET, 4TH FLOOR

WATERTOWN, MA, 02472

View on SEC.gov